Navigation Links
Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass
Date:1/26/2009

Article in Gynecologic Oncology Supports Use of Fujirebio Diagnostics'

HE4 Test with CA125 for Risk Stratification of Women with Suspected Ovarian Cancer

MALVERN, Pa., Jan. 26 /PRNewswire/ -- A pivotal clinical trial published in the January 2009 issue of the journal Gynecologic Oncology demonstrated the utility of combining Fujirebio Diagnostics' HE4 and the CA125 test as an aid in estimating the risk of epithelial ovarian cancer in premenopausal or postmenopausal women presenting with pelvic mass. The HE4 test, which is under review by the U.S. Food and Drug Administration (FDA), was reported to successfully stratify patients into high- and low-risk groups when combined with CA125.

The combination test uses the results from two simple blood tests - CA125 and HE4 - and the Risk of Ovarian Malignancy Algorithm (ROMA(TM)) to identify patients at a high risk of having ovarian cancer. CA125 is the current gold standard for monitoring patients diagnosed with ovarian cancer. The HE4 assay was recently cleared by the FDA as an aid for monitoring recurrence of epithelial ovarian cancer (EOC), the most common type of ovarian cancer. Combining the HE4 and CA125 tests may enable physicians to pre-operatively identify those patients with a high risk of malignancy.

"Research suggests that ovarian cancer patients have better outcomes and improved survival when treated by gynecologic oncologists, surgeons that are trained and specialize in the treatment of patients with EOC," said Richard G. Moore, MD, Director of Medical Education, Program in Women's Oncology at Women and Infants' Hospital, and Assistant Professor, Obstetrics and Gynecology, Brown University, Providence, R.I, and lead author of the Gynecologic Oncology paper. "Combining measurements of HE4 and CA125 helps us to identify women who are at high risk of ovarian cancer when they present with an ovarian cyst or mass. T
'/>"/>

SOURCE Fujirebio Diagnostics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix
2. MannKind Corporation to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes
3. Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma
4. Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints
5. PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S.
6. Third Pivotal Phase 3 Study for NicOx Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
7. Cell Therapeutics Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint
8. Cell Therapeutics Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial
9. Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD
10. Pivotal Phase III Data Confirm the Efficacy and Safety of Arpidas Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections
11. Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013 /PRNewswire/ ... VRX ) (TSX: VRX) ... directors nominated at its 2013 annual ... results of the vote for the ... below:  NameForWithheldRonald H. Farmer235,731,9341,964,748Robert A. Ingram233,865,8763,830,806Theo ...
(Date:5/21/2013)... , May 21, 2013   Regulus Therapeutics ... leading the discovery and development of innovative medicines targeting ... , Ph.D., Chief Operating Officer and Executive Vice ... Deutsche Bank 38th Annual Healthcare Conference on Wednesday, May ... being held at the Westin Boston Waterfront Hotel. ...
(Date:5/21/2013)... , May 21, 2013 RenovoRx ( ... 2013 TiE50 "Top Startup" Award at TiEcon 2013, the ... strong management team and quality of entrepreneurial ideas. RenovoRx ... the Santa Clara Convention Center. ... influential list of the most enterprising startup companies across ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces 2013 Annual Meeting Results 2Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference 2RenovoRx Named Winner of 2013 TiE50 "Top Startup" 2
... Oct. 21 PharmAthene, Inc. (NYSE Amex: ... countermeasures against biological and chemical threats, announced today that ... Richman to the position of President and Chief Executive ... and Interim Chief Executive Officer in May 2010, and ...
... RICHMOND, Calif., Oct. 21 Lumiphore Inc., a ... for use in high-value imaging, diagnostics, and therapeutics ... announced that they have signed a global agreement ... targeted radiotherapeutics and companion diagnostics. Under ...
Cached Medicine Technology:PharmAthene Appoints Eric I. Richman President and Chief Executive Officer 2PharmAthene Appoints Eric I. Richman President and Chief Executive Officer 3Algeta and Lumiphore Announce Global Agreement for the Development of Targeted Alpha-Pharmaceutical Therapeutics 2Algeta and Lumiphore Announce Global Agreement for the Development of Targeted Alpha-Pharmaceutical Therapeutics 3Algeta and Lumiphore Announce Global Agreement for the Development of Targeted Alpha-Pharmaceutical Therapeutics 4
(Date:5/21/2013)... 2013 Octo Consulting Group, an ... consulting solutions to the Federal marketplace, has named ... In the newly created role, Denny will be ... the firm’s business development function to include business ... and leading strategies to achieve the firm’s strategic ...
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay ... steroid therapy for patients having severe bouts of chronic ... Five days of glucocorticoid treatment with prednisone to treat ... days, but with fewer chances for adverse side effects, ... shorter period of treatment was not less effective than ...
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) ... of sleep apnea in children, and while removing them ... kids, it did help them with sleep, behavior and ... apnea is a condition that causes abnormal pauses in ... in sleep with the surgery, and those improvements were ...
(Date:5/21/2013)... at high risk for developing lung cancer shows that ... helping clinicians spot tiny lung nodules which, in a ... of the disease. LDCT uses less than a quarter ... Results of the study will be presented at the ... leading cause of cancer-related death and has a poor ...
(Date:5/21/2013)... Mexican young adults may have a genetic predisposition for ... a study at the Universidad Autnoma de San Luis ... from both parents were already 15 pounds heavier and ... hadn,t. They also had slightly higher fasting glucose levels," ... food science and human nutrition. , In the study, ...
Breaking Medicine News(10 mins):Health News:Octo Consulting Group Appoints Tracy Denny as Vice President of Business Development 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 3Health News:Removing Tonsils Helps Kids With Sleep Apnea, Study Finds 2Health News:Removing Tonsils Helps Kids With Sleep Apnea, Study Finds 3Health News:Low radiation scans help identify cancer in earliest stages 2Health News:Low radiation scans help identify cancer in earliest stages 3Health News:Genetic risk for obesity found in many Mexican young adults 2
... Treatment of heart patients no better after performance data released ... -- One might assume that public report cards ranking their ... study finds that isn,t the case. , Researchers found ... better job of treating heart patients after report cards were ...
... , ... November 16, 2009. , ... November 18, 2009 -- Ziosoft®, Inc. http://www.ziosoftinc.com -- a leader in advanced visualization ... vice president, sales and marketing, effective November 16., , , , ,Most recently, Royea served ...
... ... and Security Suite to deliver end-to-end endpoint management solution capabilities on a single ... ... 2009 -- Lumension , a global leader in endpoint management and security, ...
... Physicians for Social Responsibility today released a groundbreaking ... look at the devastating impacts of coal on the human body. ... organ systems of the human body, the report concludes that coal ... the U.S. and is responsible for increasing the incidence of major ...
... , MINEOLA, N.Y., Nov. 18 The United ... for when a woman should be getting a mammography. ... has made an official statement regarding her research and ... , Yesterday, The United States Preventive Services Task ...
... , BRIGHTON, Mass., Nov. 18 Sleep Health Centers ... US, is proud to announce the formation of SleepPartners ( ... accredited sleep centers with board-certified sleep specialists and a focus ... sleep programs combined with their geographic reach extends high quality ...
Cached Medicine News:Health News:Study Shows Hospital Report Cards Unlikely to Spur Improvement 2Health News:Ziosoft Announces the Appointment of Rob Royea, Vice President, Sales and Marketing 2Health News:Lumension Endpoint Management Platform Strategy to Reduce Complexity, Enhance Security & Compliance, and Expand Visibility across IT Operations and Security Functions 2Health News:Lumension Endpoint Management Platform Strategy to Reduce Complexity, Enhance Security & Compliance, and Expand Visibility across IT Operations and Security Functions 3Health News:Lumension Endpoint Management Platform Strategy to Reduce Complexity, Enhance Security & Compliance, and Expand Visibility across IT Operations and Security Functions 4Health News:Lumension Endpoint Management Platform Strategy to Reduce Complexity, Enhance Security & Compliance, and Expand Visibility across IT Operations and Security Functions 5Health News:Lumension Endpoint Management Platform Strategy to Reduce Complexity, Enhance Security & Compliance, and Expand Visibility across IT Operations and Security Functions 6Health News:Lumension Endpoint Management Platform Strategy to Reduce Complexity, Enhance Security & Compliance, and Expand Visibility across IT Operations and Security Functions 7Health News:Lumension Endpoint Management Platform Strategy to Reduce Complexity, Enhance Security & Compliance, and Expand Visibility across IT Operations and Security Functions 8Health News:Coal Pollution Damages Human Health at Every Stage of Coal Life Cycle, Reports Physicians for Social Responsibility 2Health News:Coal Pollution Damages Human Health at Every Stage of Coal Life Cycle, Reports Physicians for Social Responsibility 3Health News:Coal Pollution Damages Human Health at Every Stage of Coal Life Cycle, Reports Physicians for Social Responsibility 4Health News:Coal Pollution Damages Human Health at Every Stage of Coal Life Cycle, Reports Physicians for Social Responsibility 5Health News:Maurer Foundation for Breast Health Education Statement on USPSTF Guidelines for Mammography 2Health News:Sleep HealthCenters Launches SleepPartners(TM) Network 2
... An Antiseptic Antibacterial that does ... than 30 seconds, destroys over ... used for cleansing of minor ... for disinfection of personal utensils ...
... Bactericide, Microbicide for professional degerming, pre-op ... skin disinfectants combining quaternary and substituted ... blend of emollients and surfactants. Unprecedented ... organisms tested in 30 seconds. Techni-Care ...
Aplicare's disposable 1-ounce pouches are designed for individual application and are ideal for reducing waste. They are used in nursing homes, home healthcare settings, blood banks, laboratories, em...
... solution is for broad-spectrum germicidal ... is labeled for single use ... contamination. The controlled spray mist ... the final step of the ...
Medicine Products: